Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)

• Status: Completed
• Trial end date: 2005-08-04
• Target enrollment: 0
• Participant gender: All

Summary

Collecting local data, safety and experience trial.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Ezetimibe; Simvastatin

Criteria

Inclusion Criteria:

• Patients; Post Acute Coronary Syndrome

Exclusion Criteria:

-